Livtencity 200 mg

Livtencity 200 mg is a medicine authorised by Swissmedic under authorisation number 68492. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 July 2023 and the authorisation is limited until 18 July 2028. ATC code J05AX10 places the medicine in the group Antivirals for systemic use.

Dispensing category A
Authorisation number 68492
ATC J05AX10
Synthetic medicines

Authorisation data
Authorisation number	68492
Name	Livtencity 200 mg
Full name	Livtencity 200 mg, Filmtabletten
Authorisation holder	Takeda Pharma AG
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	J05AX10
First authorisation	19 July 2023
Authorisation validity	18 July 2028

Strengths
No.	Name	Dispensing category	Authorisation date
1	Livtencity 200 mg, Filmtabletten	A	19 July 2023

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	28	Tablette(n)	J05AX10	08.03.0.	A
2	56	Tablette(n)	J05AX10	08.03.0.	A

Scroll the table sideways

Other medicines from this authorisation holder

Adcetris 50 mgAuthorisation number 62132 · ATC L01FX05A Advate 250 IE (5 ml)Authorisation number 56352 · ATC B02BD02B Adynovi 250 IE (5 ml)Authorisation number 65953 · ATC B02BD02B Adzynma 500 I.E.Authorisation number 69562 · ATC B01AD13B Agopton 30 mgAuthorisation number 51969 · ATC A02BC03B Alunbrig 30 mgAuthorisation number 66738 · ATC L01ED04A Ceprotin 500 I.E.Authorisation number 56124 · ATC B01AD12B Cinryze 500 IEAuthorisation number 61636 · ATC B06AC01B

Frequently asked questions

Is Livtencity 200 mg authorised in Switzerland?

Yes. Livtencity 200 mg is authorised by Swissmedic under authorisation number 68492, data as of 01 September 2026. The authorisation is limited until 18 July 2028.

Which dispensing category does Livtencity 200 mg have?

Livtencity 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Livtencity 200 mg?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.